Mondaq Asia Pacific: Food, Drugs, Healthcare, Life Sciences
Dentons
There have been significant developments in the Australian medicinal cannabis industry with the Turnbull Government now permitting the export of Australian manufactured medicinal cannabis products.
Holman Webb
All food utensils, no matter how stylish or fashionable, must comply with the requirements of the Food Standards Code.
CMS Cameron McKenna Nabarro Olswang LLP
The draft is open for public comments until 25 November 2017.
CMS Cameron McKenna Nabarro Olswang LLP
On 8 October 2017, the General Office of the State Council issued the Opinions on Deepening the Reform of the Evaluation and Approval System and Encouraging the Innovation of Drugs and Medical Devices.
CMS Cameron McKenna Nabarro Olswang LLP
Circular (2014) No.15 provides for the specific deadlines for different domestic medical devices manufacturing companies to gradually meet the Medical Devices Manufacturing Quality Management Standards
HFG Law Firm
O Parbleu! Thunderclap for the cheese gourmet! Recently China undertakes strengthened regulatory measures which have directly affected the long-term importation of certain types of European cheese...
CMS Cameron McKenna Nabarro Olswang LLP
The China Food and Drug Administration ("CFDA") promulgated a new circular (2017) No.68 related to the promotion of a drug market authorization holder regime ("MAH Regime") work on 21 August 2017...
Jincheng Tongda & Neal
China has been endeavoring to make comprehensive and fundamental regulatory reform of drug and medical device, in particular in the drug and medical device registration system.
Ropes & Gray LLP
The CFDA is soliciting public comments for these drafts until mid-January 2018.
MyLink Law Office
On 6 June 2016, China Food and Drug Administration ("CFDA") published Administrative Measures on Product Formula Registration of Infant Formula Milk Powder ("Measures") for purpose...
A&Z Law Firm
On September 24th, Ding Jianhua, director of the China Food and Drug Administration (CFDA) Supervision Department, stated at the 2017 Chinese Pharmaceutical Entrepreneurs, Scientists...
CMS Cameron McKenna Nabarro Olswang LLP
After receiving comments on the draft of the Decision of the State Administration of Food and Drug Administration on Adjusting the Relevant Issues Concerning the Registration and Administration...
A&Z Law Firm
Lately many restaurants in Shanghai have been broadcasting the work environment in the kitchen at their entrance (in real-time). What is that about?
Zhong Lun Law Firm
On October 23, 2017, the China Food and Drug Administration ("CFDA") released the revised Administrative Measures for Drug Registration ("Draft for Comment") for public comment.
CMS Cameron McKenna Nabarro Olswang LLP
After the State Council issued the Opinions on Deepening the Reform of Examination and Approval System and Encouraging Innovation of Drugs and Medical Devices ("Opinions") on 8 October 2017, ...
Ropes & Gray LLP
The opinions will create a level playground for R&D-focused drug and device companies, at home and abroad.
Ropes & Gray LLP
The China Food and Drug Administration (CFDA) has published its proposed amendment of the Medical Device Regulations (MDR), previously known as the State Council Order # 650, for public comments.
Ropes & Gray LLP
The China Food and Drug Administration (CFDA) published its proposed amendment of the Drug Administration Law (DAL) and the Drug Registration Rules (DRR) for public comments. This Alert summarizes the key changes.
Ropes & Gray LLP
In addition, the Final Policy attempts to strike a balance between the potentially conflicting interest of innovative and generic drug manufacturers.
McDermott Will & Emery
Hospitals in China differ greatly from those in the west with respect to their relationships with physicians and patients; but they also share some of the same legal challenges faced by western hospitals.
Latest Video
Most Popular Recent Articles
Norton Rose Fulbright Australia
Businesses in food and agriculture industries should be particularly alive to the risk of slavery in their supply chains.
Norton Rose Fulbright Australia
The article considers the responses to some of the key recommendations and potential implications of these responses.
Carroll & O'Dea
The appeal addressed how the trial judge could properly choose between competing expert opinions on mental harm.
Holman Webb
A genomic profile may help a doctor make personalised health decisions, but also raises a number of ethical challenges.
Holman Webb
Future action for non-compliance with the ACL in the marketing of therapeutic goods may result in much higher penalties.
Carroll & O'Dea
This article focuses on some information provision issues addressed in the new ethical guidelines on the use of ART.
Holman Webb
The Appeal decision confirms the need to understand medical malpractice and civil liability policy terms and conditions.
Carroll & O'Dea
The balancing exercise between confidentiality and the patient's potential risk to the community has become no easier.
Holman Webb
There are significant legal issues to consider for marketers of therapeutic goods.
Sparke Helmore Lawyers
A string of successful prosecutions by the Food Authority should alert businesses to comply with food safety obligations.
Article Search Using Filters
Related Topics
Mondaq Advice Centre (MACs)
Popular Authors
Popular Contributors
Up-coming Events Search
Tools
Font Size:
Translation
Channels
Mondaq on Twitter